Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging study of ORKA-001 in adults with moderate-to-severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)
An observational study validating the DermCLCI-p instrument for cumulative life course impairment in adults with moderate to severe chronic …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy [Phase 3]
A Phase 3 clinical trial evaluating switching to Picankibart in Chinese patients with plaque psoriasis who had an inadequate response to IL-…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients [Phase 4]
A Phase 4 clinical trial is evaluating the combination of Metformin and Secukinumab for moderate-to-severe plaque psoriasis in overweight or…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial is evaluating deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis, assessing…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
This is a Phase 2 trial update for ORKA-001 versus placebo in moderate-to-severe plaque psoriasis; the study is currently ACTIVE_NOT_RECRUIT…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) [Phase 3]
Phase 3 clinical trial update assessing JNJ-77242113 for plaque psoriasis involving special areas (scalp, genital, palms, and/or soles), cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) [Phase 3]
Phase 3 trial ICONIC-ADVANCE 2 evaluating JNJ-77242113 for moderate-to-severe plaque psoriasis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating JNJ-77242113 for moderate to severe plaque psoriasis is currently active but not recruiting.
-
FDA approval · 2026-03-06FDA Approved: SKYRIZI — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for SKYRIZI (risankizumab-rzaa) from AbbVie Inc. The action updates or expands the drug's regulatory…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
This clinical trial update describes a regulatory post-marketing surveillance study of Secukinumab (Cosentyx) in Korean patients with hidrad…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of IRX4204 for mild-to-moderate plaque psoriasis has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
An observational real-world study examining the use of tildrakizumab in adults with moderate to severe plaque psoriasis in routine clinical …
-
FDA label_change · 2026-02-27FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for SILIQ (brodalumab) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2, Phase 3]
A clinical trial evaluating CMS-D001 tablets for adults with moderate to severe plaque psoriasis, currently in Phase 2/Phase 3 and not yet r…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis [Phase 3]
An ongoing Phase 3 trial compares CT-P55, a secukinumab biosimilar, with Cosentyx (secukinumab) for moderate to severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 study evaluating the efficacy and safety of bimekizumab in Chinese adults with moderate to severe plaque psoriasis has completed w…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis [EARLY_Phase 1]
An early-phase 1 trial is evaluating the synergistic effects of triamcinolone and vitamin D3 for plaque psoriasis, and the study is currentl…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: A Registry of Patients With Moderate to Severe Plaque Psoriasis
This is a completed clinical trial registry update for patients with moderate to severe plaque psoriasis, sponsored by Novartis.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Modifying PEST for Psoriatic Arthritis Screening [NA]
Clinical Trial Update noting modifications to the Psoriasis Epidemiology Screening Tool (PEST) for screening Psoriatic Arthritis, sponsored …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Role of Insulin Action in Psoriasis Pathogenesis
Columbia University sponsored a clinical trial investigating the role of insulin action in psoriasis pathogenesis has been terminated. The s…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. [Phase 2]
A Phase 2 clinical trial comparing acupuncture with a Chinese herbal cream to acupuncture with calcipotriol for plaque psoriasis, currently …